Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (201-210 of 927) with videos related to

Pageof 93
Sort By:
Plos One|September 29, 2017
Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese womenTheodora W Elffers, Renée de Mutsert, Hildo J Lamb, et al.
Blood|December 8, 2009
Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcomeElim Y L Cheung, Hans L Vos, Marieke J H A Kruip, et al.
Frontiers in Cardiovascular Medicine|February 15, 2021
P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3<sup>*</sup>Leiden Mice via Systemic Inhibition of Regulatory T CellsAlwin de Jong, Rob C M de Jong, Erna A Peters, et al.
Current Medical Research and Opinion|July 29, 2008
Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statinsSandrin C Bergheanu, Theo Reijmers, Aeilko H Zwinderman, et al.
Scientific Reports|May 2, 2018
Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory responseRob C M de Jong, Niek J Pluijmert, Margreet R de Vries, et al.
JACC. Basic to Translational Science|January 11, 2021
Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory ResponseNiek J Pluijmert, Rob C M de Jong, Margreet R de Vries, et al.
Plos One|August 11, 2012
Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER StudyJeffrey J W Verschuren, Stella Trompet, Iris Postmus, et al.
Cardiology and Therapy|February 13, 2024
The Clear Value of Coronary Artery Calcification Evaluation on Non-Gated Chest Computed Tomography for Cardiac Risk StratificationRoos A Groen, J Wouter Jukema, Paul R M van Dijkman, et al.
Frontiers in Cardiovascular Medicine|July 12, 2023
The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart diseaseRalph M L Neijenhuis, Marieke Nederend, Monique R M Jongbloed, et al.
Acta Cardiologica|July 28, 2006
Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS)Anke-Hilse Maitland-van der Zee, J Wouter Jukema, Aeilko H Zwinderman, et al.
Pageof 93

Showing results (201-210 of 927) with videos related to

Sort By:
Pageof 93
Plos One|September 29, 2017
Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese womenTheodora W Elffers, Renée de Mutsert, Hildo J Lamb, et al.
Blood|December 8, 2009
Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcomeElim Y L Cheung, Hans L Vos, Marieke J H A Kruip, et al.
Frontiers in Cardiovascular Medicine|February 15, 2021
P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3<sup>*</sup>Leiden Mice via Systemic Inhibition of Regulatory T CellsAlwin de Jong, Rob C M de Jong, Erna A Peters, et al.
Current Medical Research and Opinion|July 29, 2008
Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statinsSandrin C Bergheanu, Theo Reijmers, Aeilko H Zwinderman, et al.
Scientific Reports|May 2, 2018
Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory responseRob C M de Jong, Niek J Pluijmert, Margreet R de Vries, et al.
JACC. Basic to Translational Science|January 11, 2021
Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory ResponseNiek J Pluijmert, Rob C M de Jong, Margreet R de Vries, et al.
Plos One|August 11, 2012
Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER StudyJeffrey J W Verschuren, Stella Trompet, Iris Postmus, et al.
Cardiology and Therapy|February 13, 2024
The Clear Value of Coronary Artery Calcification Evaluation on Non-Gated Chest Computed Tomography for Cardiac Risk StratificationRoos A Groen, J Wouter Jukema, Paul R M van Dijkman, et al.
Frontiers in Cardiovascular Medicine|July 12, 2023
The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart diseaseRalph M L Neijenhuis, Marieke Nederend, Monique R M Jongbloed, et al.
Acta Cardiologica|July 28, 2006
Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS)Anke-Hilse Maitland-van der Zee, J Wouter Jukema, Aeilko H Zwinderman, et al.
Pageof 93